Expertise in
1
conditions

Markus C. Fleisch

Wuppertal, NW, DE 
Expertise in
1
conditions
Wuppertal, NW, DE 

Overview

Markus Fleisch practices practicing medicine in Wuppertal, Germany.

Mr. Fleisch is highly rated in 1 condition, according to our data. His clinical expertise encompasses Triple-Negative Breast Cancer, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, Endometrial Cancer, and Cowden Syndrome.

He is actively involved in clinical research, co-authoring 42 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Wuppertal, NW, Germany
Other Locations
Witten, NW, Germany
Garching Bei Munchen, BY 85747, Germany
Neuherberg, BY, Germany
Duesseldorf, NW 40225, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized Phase III Trial of Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab Versus Platinum Chemotherapy Plus Paclitaxel and Bevacizumab in Metastatic (Stage IVB), Persistent, or Recurrent Carcinoma of the Cervix
A Randomized Phase III Trial of Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab Versus Platinum Chemotherapy Plus Paclitaxel and Bevacizumab in Metastatic (Stage IVB), Persistent, or Recurrent Carcinoma of the Cervix
Enrollment Status: Completed
Publish Date: April 21, 2026
Intervention Type: Drug
Study Drugs: Bevacizumab, Cisplatin, Carboplatin, Paclitaxel, Atezolizumab
Study Phase: Phase 3

42 Total Publications

Concordance of Preoperative Transvaginal Ultrasound and Intraoperative Findings in Fibroid Ablation Using Transcervical Ultrasound: A Two-Center Cohort Study.
Concordance of Preoperative Transvaginal Ultrasound and Intraoperative Findings in Fibroid Ablation Using Transcervical Ultrasound: A Two-Center Cohort Study.
Journal: Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
Published: February 11, 2026

Frequently Asked Questions about Markus C. Fleisch

Is Markus C. Fleisch a top-rated expert for Triple-Negative Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Markus C. Fleisch is classified as an Advanced expert for Triple-Negative Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Markus C. Fleisch participate in research or clinical trials?

Yes. Markus C. Fleisch has published 42 articles and abstracts on conditions like Triple-Negative Breast Cancer. You can view a list of Markus C. Fleisch's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Fleisch's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile